Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending February 12, 2007. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the Company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
The filing details specific transfers of Ordinary Shares from the GlaxoSmithKline Employee Trust ("the GSK Trust") to participants in the SmithKline Beecham Employee Share Option Plan 1991:
- February 8, 2007: Transfer of 478,162 Ordinary Shares.
- February 9, 2007: Transfer of 191,242 Ordinary Shares.
Three directors (Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop) are noted as having an interest in the shares held in the GSK Trust in the same capacity as other employees.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of the aforementioned share transactions in accordance with Disclosure Rule 3.1.4R(1)(b).
Investor Verification Points
- Confirm the total number of shares transferred to the SmithKline Beecham Employee Share Option Plan 1991 during the reporting period (669,404 shares).
- Verify the status of the GSK Trust as a discretionary trust for current and former employees.
- Note that the filing was signed by Victoria Whyte as the Authorised Signatory on February 12, 2007.